For the past ten years, the Institute for Pediatric Innovation (IPI) has been bringing together “clinicians, innovators, industry, and patients to develop new medical devices and medicines specifically for children.” Headquartered in Cambridge, MA, IPI holds a number of programs and writes reports geared towards productive collaboration on medical issues facing pediatric medicine.
IPI’s Clinical Innovation Catalyst Program brings together clinicians to “develop solutions to a specific pediatric health challenge through a series of innovation training workshops.” Similarly, recognizing that pediatric medical device technology “often lags five to ten years behind new technology for adults,” IPI worked with Pfizer to create the IPI/Pfizer Device Challenge to foster pediatric medical device innovation. IPI is also a founding member of the FDA-funded New England Pediatric Device Consortium, which assists companies in commercializing medical devices.
IPI recognizes the disproportionately small amount of healthcare dollars spent on child healthcare and drug development. In response, IPI created the Global Alliance for Pediatric Therapeutics to bring together “pharmaceutical companies, hospital and medical school specialists, government agencies, and parents and children” to address the challenges facing pediatric therapeutics.
The New England Council is excited to welcome the Institute for Pediatric Innovation and looks forward to their active participation on our Technology and Healthcare Committees.
09/13/2021 | Read Post
09/13/2021 | Read Post
08/2/2021 | Read Press Release
04/27/2021 | Read Press Release